Clinical Trial Update: Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, tolerability, and effects of ubiquinol on oxidative damage and mitochondrial biomarkers in Parkinson disease; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ubiquinol (ubiquinol)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-05-23